IBRX vs. INBS

Last updated Apr 1, 2026

Compare and contrast key facts about ImmunityBio, Inc. (IBRX) and Intelligent Bio Solutions Inc. (INBS).

Performance

IBRX vs. INBS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ImmunityBio, Inc. (IBRX) and Intelligent Bio Solutions Inc. (INBS). The values are adjusted to include any dividend payments, if applicable.

IBRX vs. INBS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
IBRX ImmunityBio, Inc.	287.37%	-22.66%	-49.00%	-0.99%	-16.61%	-54.39%	-24.30%
INBS Intelligent Bio Solutions Inc.	-64.90%	-31.93%	-65.47%	-91.55%	-86.07%	-80.61%	-32.85%

Fundamentals

Market Cap IBRX : $7.59B INBS : $3.18M
EPS IBRX : -$0.37 INBS : -$14.52
PS Ratio IBRX : 63.74 INBS : 0.73
Total Revenue (TTM) IBRX : $113.29M INBS : $3.58M
Gross Profit (TTM) IBRX : $112.54M INBS : $1.65M
EBITDA (TTM) IBRX : -$257.20M INBS : -$10.62M

Returns By Period

In the year-to-date period, IBRX achieves a 287.37% return, which is significantly higher than INBS's -64.90% return.

IBRX

• 1D: 15.17%
• 1M: -21.57%
• YTD: 287.37%
• 6M: 211.79%
• 1Y: 154.82%
• 3Y*: 61.53%
• 5Y*: -19.29%
• 10Y*: -1.17%

INBS

• 1D: 16.55%
• 1M: -25.67%
• YTD: -64.90%
• 6M: -67.21%
• 1Y: -76.77%
• 3Y*: -78.74%
• 5Y*: -81.05%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

IBRX vs. INBS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBRX

IBRX Risk / Return Rank: 84
IBRX Sharpe Ratio Rank: 84
IBRX Sortino Ratio Rank: 87
IBRX Omega Ratio Rank: 83
IBRX Calmar Ratio Rank: 88
IBRX Martin Ratio Rank: 79

INBS

INBS Risk / Return Rank: 16
INBS Sharpe Ratio Rank: 21
INBS Sortino Ratio Rank: 20
INBS Omega Ratio Rank: 21
INBS Calmar Ratio Rank: 8
INBS Martin Ratio Rank: 9

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBRX vs. INBS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ImmunityBio, Inc. (IBRX) and Intelligent Bio Solutions Inc. (INBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IBRX	INBS	Difference
Sharpe ratio Return per unit of total volatility	1.44	-0.45	+1.88
Sortino ratio Return per unit of downside risk	2.54	-0.49	+3.03
Omega ratio Gain probability vs. loss probability	1.31	0.94	+0.36
Calmar ratio Return relative to maximum drawdown	3.40	-0.89	+4.29
Martin ratio Return relative to average drawdown	5.58	-1.54	+7.12
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IBRX vs. INBS - Sharpe Ratio Comparison

The current IBRX Sharpe Ratio is 1.44, which is higher than the INBS Sharpe Ratio of -0.45. The chart below compares the historical Sharpe Ratios of IBRX and INBS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	IBRX	INBS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.44	-0.45	+1.88
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.17	-0.38	+0.21
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.01	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.12	-0.39	+0.27

Correlation

The correlation between IBRX and INBS is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

IBRX vs. INBS - Dividend Comparison

Neither IBRX nor INBS has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

IBRX vs. INBS - Drawdown Comparison

The maximum IBRX drawdown since its inception was -97.14%, roughly equal to the maximum INBS drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for IBRX and INBS.

Drawdown Indicators

	IBRX	INBS	Difference
Max Drawdown Largest peak-to-trough decline	-97.14%	-99.99%	+2.85%
Max Drawdown (1Y) Largest decline over 1 year	-42.44%	-87.24%	+44.80%
Max Drawdown (5Y) Largest decline over 5 years	-94.40%	-99.98%	+5.58%
Max Drawdown (10Y) Largest decline over 10 years	-97.03%	—	—
Current Drawdown Current decline from peak	-81.85%	-99.99%	+18.14%
Average Drawdown Average peak-to-trough decline	-83.94%	-91.26%	+7.32%
Ulcer Index Depth and duration of drawdowns from previous peaks	25.86%	50.60%	-24.74%

Volatility

IBRX vs. INBS - Volatility Comparison

ImmunityBio, Inc. (IBRX) has a higher volatility of 38.29% compared to Intelligent Bio Solutions Inc. (INBS) at 25.13%. This indicates that IBRX's price experiences larger fluctuations and is considered to be riskier than INBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IBRX	INBS	Difference
Volatility (1M) Calculated over the trailing 1-month period	38.29%	25.13%	+13.16%
Volatility (6M) Calculated over the trailing 6-month period	87.83%	122.87%	-35.04%
Volatility (1Y) Calculated over the trailing 1-year period	108.55%	172.12%	-63.57%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	113.60%	215.77%	-102.17%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	111.61%	211.54%	-99.93%

Financials